Skip to main content
. 2021 Oct 25;11:755113. doi: 10.3389/fonc.2021.755113

Figure 3.

Figure 3

(A) Survival in patients with no high risk and <65 of age who received chemotherapy (n = 134) versus no chemotherapy (n = 532). (B) Survival in patients with no high risk and ≥65 of age who received chemotherapy (n = 53) versus no chemotherapy (n = 153). (C) Survival in patients with high risk and <65 of age who received chemotherapy (n = 161) versus no chemotherapy (n = 129). (D) Survival in patients with high risk and ≥65 of age who received chemotherapy (n = 83) versus no chemotherapy (n = 303).